246 related articles for article (PubMed ID: 12817187)
1. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
[TBL] [Abstract][Full Text] [Related]
2. Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls.
Bergersen BM; Schumacher A; Sandvik L; Bruun JN; Birkeland K
Scand J Infect Dis; 2006; 38(8):682-9. PubMed ID: 16857615
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
4. Menopause is an independent predictor of metabolic syndrome in Iranian women.
Eshtiaghi R; Esteghamati A; Nakhjavani M
Maturitas; 2010 Mar; 65(3):262-6. PubMed ID: 19962253
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
6. Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome.
Gazzaruso C; Giordanetti S; La Manna A; Celsa M; De Amici E; Turpini C; Catona A; Fratino P
Obes Surg; 2002 Dec; 12(6):841-5. PubMed ID: 12568192
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
[TBL] [Abstract][Full Text] [Related]
8. Association of hypertension with cluster of insulin resistance syndrome factors: the Chennai Urban Population Study (CUPS-12).
Deepa R; Pradeepa R; Shanthirani CS; Mohan V;
Acta Diabetol; 2004 Jun; 41(2):49-55. PubMed ID: 15224205
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism in patients with essential hypertension.
García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
[TBL] [Abstract][Full Text] [Related]
10. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
[TBL] [Abstract][Full Text] [Related]
11. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
12. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.
Reilly MP; Wolfe ML; Rhodes T; Girman C; Mehta N; Rader DJ
Circulation; 2004 Aug; 110(7):803-9. PubMed ID: 15289378
[TBL] [Abstract][Full Text] [Related]
13. Can the metabolic syndrome identify children with insulin resistance?
Hirschler V; Calcagno ML; Aranda C; Maccallini G; Jadzinsky M
Pediatr Diabetes; 2007 Oct; 8(5):272-7. PubMed ID: 17850470
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
Kanauchi M; Kanauchi K; Hashimoto T; Saito Y
Curr Med Res Opin; 2004 Sep; 20(9):1365-70. PubMed ID: 15383184
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.
Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T
HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population.
Benguigui C; Bongard V; Ruidavets JB; Chamontin B; Sixou M; Ferrières J; Amar J
J Clin Periodontol; 2010 Jul; 37(7):601-8. PubMed ID: 20492076
[TBL] [Abstract][Full Text] [Related]
19. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M
Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
